Golf I probably couldn't agree more with your post. To me though the biggest thing right now is why hasn't this trial begun?  Perhaps one of the science posters could shed some light as to a valid reason this has taken so long?  

In March of 2020, 15 months ago!, Don said in a press release "Resverlogix stands ready...." and "We must act quickly" and this past February he said they would be enrolling patients almost immediately. We have also been told the trial is short, inexpensive and can be self funded. The outside verification of the potential is outstanding so why the foot dragging and why not inform shareholders as to where in the process we are and why the huge discrepancy between what Don said and where we are. Just incompetence??  To me this is a golden opportunity to start communicating with the market accurately and honestly but seems management has zero inclination to do so. Why?  If they want to know why the share price is so pathetic they just need to review their own inaction.